WCM
Wedge Capital Management Portfolio holdings
AUM
$5.6B
This Quarter Return
+8.8%
1 Year Return
+23.19%
3 Year Return
+97.17%
5 Year Return
+207.91%
10 Year Return
+330.87%
AUM
$6.28B
AUM Growth
+$6.28B
(+5.9%)
Cap. Flow
+$70.6M
Cap. Flow
% of AUM
1.12%
Top 10 Holdings %
Top 10 Hldgs %
13.23%
Holding
536
New
110
Increased
138
Reduced
255
Closed
31
Top Buys
| 1 |
ON Semiconductor
ON
|
$80.9M |
| 2 |
Super Micro Computer
SMCI
|
$80.8M |
| 3 |
Applied Materials
AMAT
|
$80M |
| 4 |
Tenet Healthcare
THC
|
$40M |
| 5 |
DaVita
DVA
|
$36.3M |
Top Sells
| 1 |
Amphenol
APH
|
$76.1M |
| 2 |
CDW
CDW
|
$69.9M |
| 3 |
Ross Stores
ROST
|
$30.5M |
| 4 |
Ulta Beauty
ULTA
|
$30.5M |
| 5 |
BJs Wholesale Club
BJ
|
$29.8M |
Sector Composition
| 1 | Technology | 23.71% |
| 2 | Consumer Discretionary | 15.25% |
| 3 | Financials | 14.98% |
| 4 | Healthcare | 14.82% |
| 5 | Industrials | 11.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Royal Caribbean
RCL
$96.4B
| $32.4M | 0.52% |
+311,939
| New | +$32.4M |
|
52
AXIS Capital
AXS
$7.68B
| $32.3M | 0.51% |
600,679
-77,729
| -11% | -$4.18M |
|
53
Taylor Morrison
TMHC
$6.67B
| $32.2M | 0.51% |
659,592
+653,820
| +11,327% | +$31.9M |
|
54
CVS Health
CVS
$93B
| $31.9M | 0.51% |
461,509
-24,512
| -5% | -$1.69M |
|
55
Centene
CNC
$14.8B
| $31.8M | 0.51% |
472,185
-94,318
| -17% | -$6.36M |
|
56
Amgen
AMGN
$153B
| $31.6M | 0.5% |
142,502
-20,234
| -12% | -$4.49M |
|
57
Casey's General Stores
CASY
$18.6B
| $31.3M | 0.5% |
128,440
-15,047
| -10% | -$3.67M |
|
58
Dillards
DDS
$8.73B
| $31.3M | 0.5% |
95,854
+8,747
| +10% | +$2.85M |
|
59
Hartford Financial Services
HIG
$37.4B
| $31.2M | 0.5% |
433,189
-21,244
| -5% | -$1.53M |
|
60
Deckers Outdoor
DECK
$18.3B
| $30.8M | 0.49% |
58,447
-4,837
| -8% | -$2.55M |
|
61
AbbVie
ABBV
$374B
| $30.8M | 0.49% |
228,612
-9,655
| -4% | -$1.3M |
|
62
Bristol-Myers Squibb
BMY
$96.7B
| $30.7M | 0.49% |
480,019
-70,327
| -13% | -$4.5M |
|
63
Franklin Resources
BEN
$13.3B
| $30.6M | 0.49% |
1,145,067
-7,783
| -0.7% | -$208K |
|
64
State Street
STT
$32.1B
| $30.5M | 0.48% |
+416,110
| New | +$30.5M |
|
65
Biogen
BIIB
$20.8B
| $30.4M | 0.48% |
106,815
-34,811
| -25% | -$9.92M |
|
66
Bio-Rad Laboratories Class A
BIO
$7.8B
| $30.1M | 0.48% |
+79,426
| New | +$30.1M |
|
67
J.M. Smucker
SJM
$12B
| $30.1M | 0.48% |
203,758
-36,978
| -15% | -$5.46M |
|
68
Elevance Health
ELV
$72.4B
| $30.1M | 0.48% |
67,664
-13,542
| -17% | -$6.02M |
|
69
Emcor
EME
$28.1B
| $30M | 0.48% |
162,604
+26,491
| +19% | +$4.9M |
|
70
Kroger
KR
$45.1B
| $30M | 0.48% |
638,507
-157,115
| -20% | -$7.38M |
|
71
Goldman Sachs
GS
$221B
| $30M | 0.48% |
92,994
-2,751
| -3% | -$887K |
|
72
D.R. Horton
DHI
$51.3B
| $29.7M | 0.47% |
+243,863
| New | +$29.7M |
|
73
Jazz Pharmaceuticals
JAZZ
$7.99B
| $29.6M | 0.47% |
239,082
-33,786
| -12% | -$4.19M |
|
74
Citigroup
C
$175B
| $29.5M | 0.47% |
640,409
-46,565
| -7% | -$2.14M |
|
75
Lennar Class A
LEN
$34.7B
| $29.4M | 0.47% |
234,609
-34,216
| -13% | -$4.29M |
|